版本:
中国

BRIEF-Kadmon presents preclinical data supporting therapeutic potential of rock inhibition in pulmonary fibrosis

March 28 Kadmon Holdings Inc

* Kadmon presents preclinical data supporting the therapeutic potential of rock inhibition in pulmonary fibrosis

* Kadmon Holdings Inc - data validate role of rock signaling in fibrotic disease

* Kadmon Holdings Inc - data demonstrate that rock inhibition blocks multiple cell signaling mechanisms that drive pulmonary fibrosis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐